UK markets open in 50 minutes
NIKKEI 225
39,509.81 +168.27 (+0.43%) HANG SENG
17,784.49 +68.02 (+0.38%) CRUDE OIL
82.27 +0.53 (+0.65%) GOLD FUTURES
2,335.90 -0.70 (-0.03%) DOW
39,164.06 +36.26 (+0.09%) Bitcoin GBP
48,658.98 +577.51 (+1.20%)
Sino Biopharmaceutical Limited (SMZ1.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 02:37PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 6.08B |
| Enterprise value | 5.89B |
| Trailing P/E | 24.33 |
| Forward P/E | 22.52 |
| PEG ratio (5-yr expected) | 1.34 |
| Price/sales (ttm) | 1.76 |
| Price/book (mrq) | 1.53 |
| Enterprise value/revenue | 1.74 |
| Enterprise value/EBITDA | 6.54 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.58 |
| 52-week change 3 | -24.98% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 0.4599 |
| 52-week low 3 | 0.2851 |
| 50-day moving average 3 | 0.3312 |
| 200-day moving average 3 | 0.3577 |
Share statistics
| Avg vol (3-month) 3 | 4.96k |
| Avg vol (10-day) 3 | 6.39k |
| Shares outstanding 5 | 18.79B |
| Implied shares outstanding 6 | 19.22B |
| Float 8 | 9.28B |
| % held by insiders 1 | 48.21% |
| % held by institutions 1 | 17.36% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.01 |
| Forward annual dividend yield 4 | 1.86% |
| Trailing annual dividend rate 3 | 0.05 |
| Trailing annual dividend yield 3 | 13.95% |
| 5-year average dividend yield 4 | 1.51 |
| Payout ratio 4 | 72.63% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 11 Jun 2024 |
| Last split factor 2 | 3:2 |
| Last split date 3 | 20 Jul 2020 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 8.90% |
| Operating margin (ttm) | 20.76% |
Management effectiveness
| Return on assets (ttm) | 5.33% |
| Return on equity (ttm) | 12.12% |
Income statement
| Revenue (ttm) | 26.2B |
| Revenue per share (ttm) | 1.41 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | 6.38B |
| Net income avi to common (ttm) | 1.85B |
| Diluted EPS (ttm) | 0.0100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 14.12B |
| Total cash per share (mrq) | 0.77 |
| Total debt (mrq) | 12.72B |
| Total debt/equity (mrq) | 33.31% |
| Current ratio (mrq) | 1.05 |
| Book value per share (mrq) | 1.66 |
Cash flow statement
| Operating cash flow (ttm) | 6.07B |
| Levered free cash flow (ttm) | 3.01B |
© 2024 Yahoo. All rights reserved.